BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10514242)

  • 1. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody.
    Pande R; Leis AA
    Muscle Nerve; 1999 Nov; 22(11):1600-2. PubMed ID: 10514242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neuronal nicotinic receptor antibodies in MG patients with thymoma.
    Gotti C; Moretti M; Mantegazza R; Fornasari D; Tsouloufis T; Clementi F
    J Neuroimmunol; 2001 Feb; 113(1):142-5. PubMed ID: 11137585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy.
    Vernino S; Hopkins S; Wang Z
    Auton Neurosci; 2009 Mar; 146(1-2):3-7. PubMed ID: 18951069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
    Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
    Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal pseudo-obstruction, myasthenia gravis, and thymoma.
    Anderson NE; Hutchinson DO; Nicholson GJ; Aitcheson F; Nixon JM
    Neurology; 1996 Oct; 47(4):985-7. PubMed ID: 8857731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.
    Jordan B; Schilling S; Zierz S
    J Neurol; 2016 Jan; 263(1):174-6. PubMed ID: 26645394
    [No Abstract]   [Full Text] [Related]  

  • 9. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A; Aarli JA; Matre R; Gilhus NE
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to synthetic peptide (125-148) of the alpha-subunit of human nicotinic acetylcholine receptor in sera from patients with myasthenia gravis.
    Ohta M; Ohta K; Itoh N; Nishitani H; Hara H; Hayashi K
    Neurology; 1990 Nov; 40(11):1776-8. PubMed ID: 2234435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of antibodies in myasthenia gravis.
    De Baets M; Stassen MH
    J Neurol Sci; 2002 Oct; 202(1-2):5-11. PubMed ID: 12220686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle and neuronal autoantibody markers of thymoma: neurological correlations.
    Vernino S; Lennon VA
    Ann N Y Acad Sci; 2003 Sep; 998():359-61. PubMed ID: 14592897
    [No Abstract]   [Full Text] [Related]  

  • 13. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of tacrolimus on myasthenia gravis with thymoma.
    Mitsui T; Kunishige M; Ichimiya M; Shichijo K; Endo I; Matsumoto T
    Neurologist; 2007 Mar; 13(2):83-6. PubMed ID: 17351528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas.
    Mineo TC; Tamburrini A; Schillaci O; Ambrogi V
    Semin Thorac Cardiovasc Surg; 2018; 30(2):222-227. PubMed ID: 29522809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seropositive myasthenia and autoimmune autonomic ganglionopathy: cross reactivity or subclinical disease?
    Miglis MG; Racela R; Kaufmann H
    Auton Neurosci; 2011 Oct; 164(1-2):87-8. PubMed ID: 21745762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.
    Zekeridou A; McKeon A; Lennon VA
    JAMA Neurol; 2016 Jul; 73(7):853-9. PubMed ID: 27135398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antirapsyn antibodies occur commonly in patients with lupus.
    Agius MA; Zhu S; Aarli JA
    Ann N Y Acad Sci; 1998 May; 841():525-6. PubMed ID: 9668286
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up study of relapse in symptoms and reelevation of acetylcholine receptor antibody titers in patients with myasthenia gravis.
    Komiya T; Sato T
    Ann N Y Acad Sci; 1988; 540():605-7. PubMed ID: 3207287
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
    Bogdan I; Crisanda V
    Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.